These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30257684)

  • 1. Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ.
    Lei L; Muhammad S; Al-Obaidi M; Sebire N; Cheng IL; Eleftheriou D; Brogan P
    Pediatr Rheumatol Online J; 2018 Sep; 16(1):61. PubMed ID: 30257684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-Onset Juvenile SLE Associated With a Novel Mutation in Protein Kinase C δ.
    Nanthapisal S; Omoyinmi E; Murphy C; Standing A; Eisenhut M; Eleftheriou D; Brogan PA
    Pediatrics; 2017 Jan; 139(1):. PubMed ID: 28003329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation.
    Belot A; Kasher PR; Trotter EW; Foray AP; Debaud AL; Rice GI; Szynkiewicz M; Zabot MT; Rouvet I; Bhaskar SS; Daly SB; Dickerson JE; Mayer J; O'Sullivan J; Juillard L; Urquhart JE; Fawdar S; Marusiak AA; Stephenson N; Waszkowycz B; W Beresford M; Biesecker LG; C M Black G; René C; Eliaou JF; Fabien N; Ranchin B; Cochat P; Gaffney PM; Rozenberg F; Lebon P; Malcus C; Crow YJ; Brognard J; Bonnefoy N
    Arthritis Rheum; 2013 Aug; 65(8):2161-71. PubMed ID: 23666743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab.
    Masoud S; McAdoo SP; Bedi R; Cairns TD; Lightstone L
    Rheumatology (Oxford); 2018 Jul; 57(7):1156-1161. PubMed ID: 29562252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of therapy-resistant systemic lupus erythematosus with rituximab: report of a case and review of the literature.
    Van den Bergh B; Selleslag D; Boelaert JR; Matthys EG; Schurgers M; Vandecasteele S; De Vriese A
    Acta Clin Belg; 2005; 60(2):102-5. PubMed ID: 16082997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review.
    Kara B; Ekinci Z; Sahin S; Gungor M; Gunes AS; Ozturk K; Adrovic A; Cefle A; Inanç M; Gul A; Kasapcopur O
    Rheumatol Int; 2020 Nov; 40(11):1903-1910. PubMed ID: 32691099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic Variability in PRKCD: a Review of the Literature.
    Jefferson L; Ramanan AV; Jolles S; Bernatoniene J; Mathieu AL; Belot A; Roderick MR
    J Clin Immunol; 2023 Nov; 43(8):1692-1705. PubMed ID: 37794137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentially Beneficial Effect of Hydroxychloroquine in a Patient with a Novel Mutation in Protein Kinase Cδ Deficiency.
    Kiykim A; Ogulur I; Baris S; Salzer E; Karakoc-Aydiner E; Ozen AO; Garncarz W; Hirschmugl T; Krolo A; Yucelten AD; Boztug K; Barlan IB
    J Clin Immunol; 2015 Aug; 35(6):523-6. PubMed ID: 26233237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of lymphocyte subsets to B cell-targeted therapy in systemic lupus erythematosus.
    Nakayamada S; Iwata S; Tanaka Y
    Int J Rheum Dis; 2015 Feb; 18(2):208-18. PubMed ID: 25557245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Kinase C δ: a Gatekeeper of Immune Homeostasis.
    Salzer E; Santos-Valente E; Keller B; Warnatz K; Boztug K
    J Clin Immunol; 2016 Oct; 36(7):631-40. PubMed ID: 27541826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Fukushima T; Dong L; Sakai T; Sawaki T; Miki M; Tanaka M; Masaki Y; Hirose Y; Kuwana M; Umehara H
    Lupus; 2008 Mar; 17(3):210-4. PubMed ID: 18372362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE.
    Watson L; Beresford MW; Maynes C; Pilkington C; Marks SD; Glackin Y; Tullus K
    Lupus; 2015 Jan; 24(1):10-7. PubMed ID: 25117653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M; Fujii K; Saito K; Nakayamada S; Tsujimura S; Nawata M; Tanaka Y
    Rheumatology (Oxford); 2005 Feb; 44(2):176-82. PubMed ID: 15494350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.
    Choi JH; Park DJ; Kang JH; Yim YR; Lee KE; Lee JW; Wen L; Kim TJ; Park YW; Lee JK; Lee SS
    Lupus; 2015 Oct; 24(12):1342-9. PubMed ID: 26085595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy.
    Weide R; Heymanns J; Pandorf A; Köppler H
    Lupus; 2003; 12(10):779-82. PubMed ID: 14596428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus.
    Batu ED; Koşukcu C; Taşkıran E; Sahin S; Akman S; Sözeri B; Ünsal E; Bilginer Y; Kasapcopur O; Alikaşifoğlu M; Ozen S
    J Rheumatol; 2018 Dec; 45(12):1671-1679. PubMed ID: 30008451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First case report of using Ofatumumab in kidney transplantation AB0 incompatible.
    Mancianti N; Monaci G; Rollo F; Buracchi P; Guarnieri A; Di Luca M; Martello M; Garosi G
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Kotani T; Takeuchi T; Kawasaki Y; Hirano S; Tabushi Y; Kagitani M; Makino S; Hanafusa T
    Lupus; 2006; 15(10):683-5. PubMed ID: 17120596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.